Catalyst Pharmaceuticals, Inc.Catalyst Pharmaceuticals, Inc.Catalyst Pharmaceuticals, Inc.

Catalyst Pharmaceuticals, Inc.

No trades
See on Supercharts

Price target

32.250.000.00%
The 8 analysts offering 1 year price forecasts for CPRX have a max estimate of — and a min estimate of —.

Analyst rating

Based on 8 analysts giving stock ratings to CPRX in the past 3 months.

EPS

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise

Revenue

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


CPRX EPS for the last quarter is 0.35 USD despite the estimation of 0.30 USD. In the next quarter EPS is expected to reach 0.34 USD. Track more of Catalyst Pharmaceuticals, Inc. financials and stay on top of what is up with the company.
In the next quarter Catalyst Pharmaceuticals, Inc. revenue is expected to reach ‪134.09 M‬ USD. Check out Catalyst Pharmaceuticals, Inc. revenue and earnings and make informed decisions.
According to analysts, CPRX price target is 32.25 USD with a max estimate of 38.00 USD and a min estimate of 28.00 USD. Check if this forecast comes true in a year, meanwhile watch Catalyst Pharmaceuticals, Inc. stock price chart and keep track of the current situation with CPRX news and stock market news.
We've gathered opinions of 8 analysts rating CPRX stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as strong buy. Note that it's not a trading advice — your own analysis is still required.